MRNA as gene therapeutic: How to control protein expression

Journal of Controlled Release

Volumn 150, Issue 3, 2011, Pages 238-247

  Tavernier, Geertrui ^a   Andries, Oliwia ^a   Demeester, Jo ^a   Sanders, Niek N ^a   De Smedt, Stefaan C ^a   Rejman, Joanna ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Lipoplexes; mRNA delivery; mRNA vaccines; Nuclear barrier; Poly(A)tail; Polyplexes

Indexed keywords

LIPOPLEXES; MRNA DELIVERY; MRNA VACCINES; NUCLEAR BARRIER; POLY(A)TAIL; POLYPLEXES;

GENE EXPRESSION; GENE THERAPY; GENE TRANSFER;

NUCLEIC ACIDS;

CYTOSINE; GUANINE; MESSENGER RNA; PHOSPHATE; PLASMID DNA; POLYMER; RNA VACCINE;

BRAIN HYPOXIA; CANCER IMMUNOTHERAPY; DNA BINDING MOTIF; ELECTROPORATION; GENE GUN IMMUNIZATION; GENE TARGETING; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFECTION; MOLECULAR STABILITY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; RNA IMMUNIZATION;

ANIMALS; HUMANS; IMMUNOTHERAPY; NEOPLASMS; RNA, MESSENGER; TRANSFECTION;

EID: 79955054845     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.10.020     Document Type: Review

References (147)

1. G. Koch Interaction of poliovirus-specific RNAs with HeLa cells and E. coli Curr. Top. Microbiol. Immunol. 62 1973 89 138
2. R.W. Malone, P.L. Felgner, and I.M. Verma Cationic liposome-mediated RNA transfection Proc. Natl Acad. Sci. 86 1989 6077 6081 (Pubitemid 19210605)
3. C.M. Brennan, and J.A. Steitz HuR and mRNA stability Cell. Mol. Life Sci. 58 2001 266 277 (Pubitemid 32217358)
4. J. Rejman, G. Tavernier, N. Bavarsad, J. Demeester, and S.C. De Smedt mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers J. Control. Release 147 3 2010 385 391
5. M.R. Capecchi High efficiency transformation by direct microinjection of DNA into cultured mammalian cells Cell 22 1980 479 488 (Pubitemid 11199905)
6. R. Mirzayans, A.A. Remy, and P.C. Malcom Differential expression and stability of foreign genes introduced into human fibroblasts by nuclear versus cytoplasmic microinjection Mutat. Res. 281 1992 115 122
7. A.M. Thornburn, and A.S. Alberts Efficient expression of miniprep plasmid DNA after needle micro-injection into somatic cells Biotechniques 14 1993 356 358 (Pubitemid 23086108)
8. J. Zabner, A.J. Fasbender, T. Moninger, K.A. Poellinger, and M.J. Welsh Cellular and molecular barriers to gene transfer by a cationic lipid J. Biol. Chem. 270 1995 18,997 19,007
9. M. Wilke, E. Fortunati, and M. van den Broek Test Efficacy of a peptide-based gene delivery system depends on mitotic activity Gene Ther. 3 1996 1133 1142 (Pubitemid 27036117)
10. A. Fasbender, J. Zabner, B.G. Zeiher, and M.J. Welsh A low rate of cell proliferation and reduced DNA uptake limit cationic lipid mediated gene transfer to primary cultures of ciliated human airway epithelia Gene Ther. 4 1997 1173 1180 (Pubitemid 27493879)
11. W.C. Tseng, F.R. Haselton, and T.D. Giorgio Mitosis enhances transgene expression of plasmid delivered by cationic liposomes Biochim. Biophys. Acta 1445 1999 53 64 (Pubitemid 29193207)
12. V. Escriou, M. Carrière, F. Bussone, P. Wils, and D. Scherman Critical assessment of the nuclear import of plasmid during cationic lipid-mediated gene transfer J. Gene Med. 3 2001 179 187 (Pubitemid 33685445)
13. S. Brunner, T. Sauer, S. Carotta, M. Cotten, M. Saltik, and E. Wagner Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus Gene Ther. 7 2000 401 407 (Pubitemid 30156552)
14. F. Labat-Moleur, A.M. Steffan, C. Brisson, H. Perron, O. Feugeas, P. Furstenberger, F. Oberling, E. Brambilla, and J.P. Behr An electron microscopy study into the mechanism of gene transfer with lipopolyamines Gene Ther. 3 1996 1010 1017 (Pubitemid 26397476)
15. R. Tachibana, H. Harashima, Y. Shinohara, and H. Kiwada Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors Adv. Drug Deliv. Rev. 52 2001 219 226 (Pubitemid 33097548)
16. M.E. Dowty, P. Williams, G. Zhang, J.E. Hagstrom, and J.A. Wolff Plasmid DNA entry into postmitotic nuclei of primary rat myotubes Proc. Natl Acad. Sci. USA 92 1995 4572 4576
17. P.L. Paine, L.C. Moore, and S.B. Horowitz Nuclear envelope permeability Nature 254 1975 109 114
18. A.I. Aronsohn, and J.A. Hughes Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy J. Drug Target. 5 1998 163 169 (Pubitemid 28176788)
19. C.K. Chan, and D.A. Jans Enhancement of polylysine-mediated transferrinfection by nuclear localization sequences: polylysine does not function as a nuclear localization sequence Hum. Gene Ther. 10 1999 1695 1702 (Pubitemid 29328213)
20. A. Subramanian, P. Ranganathan, and S.L. Diamond Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells Nat. Biotechnol. 17 1999 873 877 (Pubitemid 29416660)
21. M. van der Aa, G. Koning, J. van der Gugten, C. d'Oliveira, R. Oosting, W.E. Hennink, and D.J. Crommelin Covalent attachment of an NLS-peptide to linear DNA does not enhance transfection efficiency of cationic polymer based gene delivery systems J. Control. Release 101 2005 395 397
22. M.A. Zanta, P. Belguise-Valladier, and J.P. Behr Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus Proc. Natl Acad. Sci. USA 96 1999 91 96 (Pubitemid 29036058)
23. C.K. Chan, and D.A. Jans Enhancement of MSH receptor- and GAL4-mediated gene transfer by switching the nuclear import pathway Gene Ther. 2001 8
24. C. Neves, V. Escriou, G. Byk, D. Scherman, and P. Wils Intracellular fate and nuclear targeting of plasmid DNA Cell Biol. Toxicol. 15 1999 193 202 (Pubitemid 29518620)
25. C. Ciolina, G. Byk, F. Blanche, V. Thuillier, D. Scherman, and P. Wils Coupling of nuclear localization signals to plazmid DNA and specific interaction of the conjugates with importin alpha Bioconjug. Chem. 10 1999 49 55 (Pubitemid 29062517)
26. J.J. Ludtke, G.F. Zhang, M.G. Sebestyen, and J.A. Wolff A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA J. Cell Sci. 112 1999 2033 2041 (Pubitemid 29338827)
27. B. Schwartz, M.A. Ivanov, B. Pitard, V. Escriou, R. Rangara, G. Byk, P. Wils, J. Crouzet, and D. Scherman Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo Gene Ther. 6 1999 282 292 (Pubitemid 29089927)
28. M.G. Sebestyén MG, J.J. Ludtke, M.C. Bassik, G. Zhang, V. Budker, E.A. Lukhtanov, J.E. Hagstrom, and J.A. Wolff DNA vector chemistry: the covalent attachment of signal peptides to plasmid DNA Nat. Biotechnol. 16 1998 80 85 (Pubitemid 28035954)
29. C. Maucksch, A. Bohla, F. Hoffmann, M. Schleef, M.K. Aneja, M. Elfinger, D. Hartl, and C. Rudolph Transgene expression of transfected supercoiled plasmid DNA concatemers in mammalian cells J. Gene Med. 11 2009 444 453
30. P. Collas, H. Husebye, and P. Alestrom The nuclear localization sequence of the SV40T antigen promotes transgene uptake and expression in zebrafish embryo nuclei Transgenic Res. 5 1996 451 458 (Pubitemid 26367902)
31. P. Collas, and P. Alestrom Rapid targeting of plasmid DNA to zebrafish embryo nuclei by the nuclear localization signal of SV40 T antigen Mol. Mar. Biol. Biotechnol. 6 1997 48 58 (Pubitemid 27170086)
32. A. Arenal, R. Pimentel, C. García, E. Pimentel, and P. Aleström The SV40 T antigen nuclear localization sequence enhances nuclear import of vector DNA in embryos of a crustacean (Litopenaeus schmitti) Gene 337 2004 71 77 (Pubitemid 38970106)
33. P. Blomberg, M. Eskandarpour, S. Xia, C. Sylvén, and K.B. Islam Electroporation in combination with a plasmid vector containing SV40 enhancer elements results in increased and persistent gene expression in mouse muscle Biochem. Biophys. Res. Commun. 298 2002 505 510 (Pubitemid 35333687)
34. A.M. Krieg, A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, R. Teasdale, G.A. Koretzky, and D.M. Klinman CpG motifs in bacterial DNA trigger direct B-cell activation Nature 347 1995 546 549
35. Z.K. Ballas, W.L. Rasmussen, and A.M. Krieg Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA J. Immunol. 157 1996 1840 1845 (Pubitemid 126449654)
36. D.M. Klinman Immunotherapeutic uses of CpG oligodeoxynucleotides Nat. Rev. Immunol. 4 2004 249 259
37. B.M. Segal, J.T. Chang, and E.M. Shevach CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo J. Immunol. 164 2000 5683 5688 (Pubitemid 30389809)
38. A.M. Krieg A role for Toll in autoimmunity Nat. Immunol. 3 2002 423 424 (Pubitemid 34520790)
39. B. Richardson DNA methylation and autoimmune disease Clin. Immunol. 109 2003 72 79 (Pubitemid 37324744)
40. B.D. Freimark, H.P. Blezinger, V.J. Florack, J.L. Nordstrom, S.D. Long, D.S. Deshpande, S. Nochumson, and K.L. Petrak Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes J. Immunol. 160 1998 4580 4586 (Pubitemid 28217318)
41. N.S. Yew, K.X. Wang, M. Przybylska, R.G. Bagley, M. Stedman, J. Marshall, R.L. Scheule, and S.H. Cheng Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes Hum. Gene Ther. 10 1999 223 234 (Pubitemid 29070636)
42. N.S. Yew, H. Zhao, I.H. Wu, A. Song, J.D. Tousignant, M. Przybylska, and S.H. Cheng Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs Mol. Ther. 1 2000 255 262
43. J.D. Tousignant, A.L. Gates, L.A. Ingram, C.L. Johnson, J.B. Nietupski, S.H. Cheng, S.J. Eastman, and R.K. Scheule Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice Hum. Gene Ther. 11 2000 2493 2513
44. N.S. Yew, H. Zhao, M. Przybylska, I.H. Wu, J.D. Tousignant, R.K. Scheule, and S.H. Cheng CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo Mol. Ther. 5 2002 731 738 (Pubitemid 34619066)
45. J.D. Tousignant, H. Zhao, N.S. Yew, S.H. Cheng, S.J. Eastman, and R.K. Scheule DNA sequences in cationic lipid:pDNA-mediated systemic toxicities Hum. Gene Ther. 14 2003 203 214 (Pubitemid 36423440)
46. P. Renbaum, D. Abrahamove, A. Fainsod, G.G. Wilson, S. Rottem, and A. Razin Cloning, characterization, and expression in Escherichia coli of the gene coding for the CpG DNA methylase from Spiroplasma sp. strain MQ1(M.SssI) Nucleic Acids Res. 18 1990 1145 1152
47. J. Boyes, and A. Bird Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein EMBO J. 11 1992 327 333
48. J. Komura, T. Okada, and T. Ono Repression of transient expression by DNA methylation in transcribed regions of reporter genes introduced into cultured human cells Biochim. Biophys. Acta 1260 1995 73 78
49. I. Gursel, M. Gursel, H. Yamada, K.J. Ishii, F. Takeshita, and D.M. Klinman Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation J. Immunol. 171 2003 1393 1400 (Pubitemid 36900072)
50. K.J. Stacey, G.R. Young, F. Clark, D.P. Sester, T.L. Roberts, S. Naik, M.J. Sweet, and D.A. Hume The molecular basis for the lack of immunostimulatory activity of vertebrate DNA J. Immunol. 170 2003 3614 3620 (Pubitemid 36359230)
51. K. Suzuki, A. Mori, K.J. Ishii, J. Saito, D.S. Singer, D.M. Klinman, P.R. Krause, and L.D. Kohn Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides Proc. Natl Acad. Sci. USA 96 1999 2285 2290 (Pubitemid 29117906)
52. A.S. Trevani, A. Chorny, G. Salamone, M. Vermeulen, R. Gamberale, J. Schettini, S. Raiden, and J. Geffner Bacterial DNA activates human neutrophils by a CpG-independent pathway Eur. J. Immunol. 33 2003 3164 3174 (Pubitemid 37428349)
53. Y. Wang, and A.M. Krieg Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation Int. Immunol. 15 2003 223 231 (Pubitemid 36267114)
54. S. Ochoa Enzymatic Synthesis of Ribonucleic Acid Nobel Lecture 1959
55. J. Pelletier, and N. Sonenberg Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA Nature 334 1988 320 325
56. D.R. Gallie The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency Gene Dev. 5 2009 2108 2116
57. R. Parker, and U. Seth P bodies and the control of mRNA translation and degradation Mol. Cell 25 2007 635 646 (Pubitemid 46341926)
58. T.M. Franks, and J. Lykke-Andersen The control of mRNA decapping and P-body formation Mol. Cell 32 2008 605 615
59. A.E. Pasquinelli, J.E. Dahlberg, and E. Lund Reverse 5′ caps in RNAs made in vitro by phage RNA polymerase RNA 1 1995 957 967
60. J. Jemielty, J. Stepinski, M. Jaremko, D. Haber, R. Stolarski, E.R. Rhoads, and E. Darzynkiewicz Synthesis of novel mRNA 5′ cap-analogues: dinucleoside P1, P3-tri-, P1, P4-tetra-, and P1, P5-pentaphosphates Nucleosides Nucleotides Nucleic Acids 5-8 2003 691 694
61. M. Strenkowska, J. Kowalska, M. Lukaszewicz, J. Zuberek, W. Su, R.E. Rhoads, E. Darzynkiewicz, and J. Jemielity Towards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications New J. Chem. 34 5 2010 993 1007
62. F.T. Zohra, E.H. Chowdhury, S. Tada, T. Hoshiba, and T. Akaike Effective delivery with enhanced translational activity synergistically accelerates mRNA-based transfection Biochem. Biophys. Res. Commun. 358 2007 373 378 (Pubitemid 46719087)
63. G. Brawerman The role of the poly(A) sequence in mammalian messenger RNA Crit. Rev. Biochem. 10 1981 1 38
64. N. Elango, S. Elanga, P. Shivshankar, and M.S. Katz Optimized transfection of mRNA transcribed from a d(A/T)100 tail-containing vector Biochem. Biophys. Res. Commun. 330 2005 958 966 (Pubitemid 40462179)
65. J. Peng, E.L. Murray, and D.R. Schoenberg In vivo and in vitro analysis of poly(A) length effects on mRNA translation Meth. Mol. Biol. 419 2008 215 230
66. M. Mockey, C. Gonçalves, F.P. Dupuy, F.M. Lemoine, C. Pichon, and P. Midoux mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with poly(A) chains in cis and in trans for a high protein expression level Biochem. Biophys. Res. Commun. 340 2006 1062 1068 (Pubitemid 43083386)
67. T. Preiss, M. Muckenthaler, and M.W. Hentze Poly(A)-tail-promoted translation in yeast: implications for translational control RNA 4 2006 1321 1331
68. N. Sagata Meiotic maturation and arrest in animal oocytes Semin. Cell Dev. Biol. 9 1998 535 537
69. M. Yamashita Molecular mechanisms of meiotic maturation and arrest in fish and amphibian oocytes Semin. Cell Dev. Biol. 9 1998 569 579 (Pubitemid 128353022)
70. N.R. Nebrada, and I. Ferby Regulation of the meiotic cell cycle in oocytes Curr. Opin. Cell Biol. 12 2000 666 675
71. Y.M. Michel, D. Poncet, M. Piron, K.M. Kean, and A.M. Borman Cap-poly(A) synergy in mammalian cell-free extracts J. Biol. Chem. 41 2000 32,268 32,276
72. A.M. Borman, Y.M. Michel, C.E. Malnou, and K.M. Kean Free poly(A) stimulates capped mRNA translation in vitro through the eIF4g-poly(A)-binding protein interaction J. Biol. Chem. 39 2002 36,818 36,824
73. S.F. Newbury Control of mRNA stability in eukaryotes Biochem. Soc. Trans. 34 2006 30 34 (Pubitemid 43235526)
74. T. Preiss, and W.H. Hentze Dual function of the messenger RNA cap structures in poly(A)-tail-promoted translation in yeast Nature 392 1998 516 520 (Pubitemid 28168985)
75. D. Caput, B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami Identification of a common nucleotide sequence in the 3′-untranslated regions of mRNA molecules specifying inflammatory mediators Proc. Natl Acad. Sci. USA 83 1986 1670 1674 (Pubitemid 16018626)
76. G. Shaw, and R. Kamen A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation Cell 46 1986 659 667
77. J. Ross mRNA stability in mammalian cells Microbiol. Rev. 59 1995 423 450
78. R.D. Klausner, T.A. Rouault, and J.B. Harford Regulating the fate of mRNA: the control of cellular iron metabolism Cell 72 1993 19 28 (Pubitemid 23029689)
79. W. Scheper, D. Meinsma, P.E. Holthuizen, and J.S. Sussenbach Long-range RNA interaction of two sequence elements required for endo-nucleolytic cleavage of human insulin-like growth factor II mRNAs Mol. Cell. Biol. 15 1995 235 245 (Pubitemid 24379920)
80. T. Bettinger, R.C. Carlisle, M.L. Read, M. Ogris, and L.W. Seymour Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells Nucleic Acids Res. 29 2001 3882 3891 (Pubitemid 32910528)
81. M. Marin Folding at the rhythm of the rare codon beat Biotechnol. J. 3 2008 1047 1057
82. E.V. Agapov, I. Frolov, B.D. Lindenbach, B.M. Pragai, S. Schlesinger, and C.M. Rice Noncytopathic Sindbis virus RNA vectors for heterologous gene expression Proc. Natl Acad. Sci. USA 95 1998 12,989 12,994
83. M. Bitzer, S. Armeanu, U.M. Lauer, and W.J. Neubert Sendai virus vectors as an emerging negative-strand RNA viral vector system J. Gene Med. 5 2003 543 553 (Pubitemid 40310397)
84. Y. Isaka, and E. Imai Electroporation-mediated gene therapy Expert Opin. Drug Deliv. 4 2007 561 571 (Pubitemid 47532865)
85. L.M. Mir, M. Belehradek, C. Domenge, S. Orlowski, B. Poddevin, J. Jr., G. Schwaab Belehradek, B. Luboinski, and C. Paoletti Electrochemotherapy, a new antitumor treatment: first clinical trial C.R. Acad. Sci. 313 1991 613 618
86. V.F.I. Van Tendeloo, P. Ponsaerts, F. Lardon, G. Nijs, M. Lenjou, C. Van Broeckhoven, D.R. Van Bockstaele, and Z.N. Berneman Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells Blood 98 2001 49 56
87. M.F. Kalady, M.W. Onaitis, K.M. Padilla, S. Emani, D.S. Tyler, and S.K. Pruitt Enhanced dendritic cell antigen presentation in RNA-based immunotherapy J. Surg. Res. 105 2002 17 24 (Pubitemid 34713206)
88. H.J. Bontkes, D. Kramer, J.J. Ruizendaal, E.W.M. Kueter, V.F.I. Van Tendeloo, and C.J.L.M. Meijer Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxicity T cells Gene Ther. 14 2007 366 375 (Pubitemid 46231930)
89. A. Heiser, D. Coleman, J. Dannull, D. Yancey, M.A. Maurice, C.D. Lallas, P. Dahm, D. Niedzwiecki, E. Gilboa, and J. Vieweg Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors J. Clin. Invest. 109 2002 409 417 (Pubitemid 34141815)
90. E. Smits, P. Ponsaerts, M. Lenjou, G. Nijs, D.R. Van Bockstaele, Z.N. Berneman, and V.F.I. Van Tendeloo RNA-based gene transfer for adult stem cells and T cells Leukemia 18 2004 1898 1902 (Pubitemid 39530022)
91. P.M. Rabinovich, M.E. Komarovskaya, S.H. Wrzesinski, J.L. Alderman, T. Budak-Alpdogan, A. Karpikov, H. Guo, R.A. Flavell, N.-K. Cheung, S.M. Weissman, and E. Bahceci Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytes Hum. Gene Ther. 20 2009 51 60
92. J.C. Sanford, T.M. Klein, E.D. Wolf, and N. Allen Delivery of substances into cells and tissues using a particle bombardment process J. Part. Sci. Technol. 5 1987 27 37
93. N.S. Yang, J. Burkholder, B. Roberts, B. Martinell, and D. McCace In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment Proc. Natl Acad. Sci. 87 1990 9568 9572 (Pubitemid 120016484)
94. L. Cheng, P.R. Ziegelhoffer, and N.S. Yang In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment Proc. Natl Acad. Sci. USA 90 1990 4455 4459 (Pubitemid 23148923)
95. N.S. Yang, J. Burkholder, B. Roberts, B. Martinell, and D. McCabe In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment Proc. Natl Acad. Sci. USA 87 1994 9568 9596
96. 2+ flux Biochem. Biophys. Res. Commun. 234 1997 695 700 (Pubitemid 27281182)
97. R.L. Sohn, M.T. Murray, K. Schwarz, J. Nyitray, P. Purray, A.P. Franka, K.C. Palmer, L.N. Diebel, and S.A. Dulchavsky In-vivo particle mediated delivery of mRNA to mammalian tissues: ballistic and biologic effects Wound Repair Regen. 9 2001 287 296 (Pubitemid 32954892)
98. L.E. Rajagopalan, and J.S. Malter Turnover and translation of in vitro synthesized messenger RNAs in transfected, normal cells J. Ciol. Chem. 271 1996 19,871 19,876
99. P. Qiu, P. Ziegelhoffer, J. Sun, and N.S. Yang Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization Gene Ther. 3 1996 262 268 (Pubitemid 26120428)
100. L. Wasungu, and D. Hoekstra Cationic lipids, lipoplexes and intracellular delivery of genes J. Control. Release 116 2006 255 264 (Pubitemid 44854274)
101. W. Li, and F.C. Szoka Lipid-based nanoparticles for nucleic acid delivery Pharm. Res. 24 2007 438 449 (Pubitemid 46295166)
102. C. Tros de Ilarduya, M.A. Arangoa, and N. Duzgunes Transferrin-lipoplexes with protamine-condensed DNA for serum-resistant gene delivery Meth. Enzymol. 373 2003 342 356 (Pubitemid 41103293)
103. A. El Ouahabi, V. Pector, R. Fuks, M. Vandenbranden, and J.M. Ruysschaert Double long-chain amidine liposome-mediated self replication RNA transfection FEBS Lett. 380 1996 108 112 (Pubitemid 26059976)
104. D. Lu, R. Benjamin, M. Kim, R.M. Conry, and D.T. Curiel Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors Cancer Gene Ther. 1 1994 245 252
105. D. Boczkowski, S.K. Nair, D. Snyder, and E. Gilboa Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo J. Exp. Med. 184 1996 465 472 (Pubitemid 26324100)
106. F.T. Zohra, E.H. Chowdhury, T. Nagaoka, and T. Akaike Drastic effect of nanoapatite particles on liposome-mediated mRNA delivery to mammalian cells Anal. Biochem. 345 2005 164 166 (Pubitemid 41558209)
107. F.T. Zohra, E.H. Chowdhury, and T. Akaike High performance mRNA transfection through carbonate apatite-cationic liposome conjugates Biomaterials 30 2009 4006 4013
108. S. Zou, K. Scarfo, M.H. Nantz, and J.G. Hecker Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells Int. J. Pharm. 389 2010 232 243
109. J. Saenz-Badillos, S.P. Amin, and R.D. Granstein RNA as a tumor vaccine: a review of the literature Exp. Dermatol. 10 2001 143 154 (Pubitemid 32492476)
110. S. Jarnjak-Jankovic, R.D. Pettersen, S. Sæbøe-Larssen, F. Wesenberg, and G. Gaudernack Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia BMC Cancer 5 2005
111. A. Bonehill, A.M. Van Nuffel, J. Corthals, S. Tuyaerts, C. Heirman, V. François, D. Colau, P. van der Bruggen, B. Neyns, and K. Thielemans Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients Clin. Cancer Res. 15 2009 3366 3375
112. P. Ponsaerts, V.F.I. Van Tendeloo, and Z.N. Berneman Cancer immunotherapy using RNA-loaded dendritic cells Clin. Exp. Immunol. 134 2003 378 384 (Pubitemid 37542075)
113. E. Gilboa, and J. Vieweg Cancer immunotherapy with mRNA-transfected dendritic cells Immunol. Rev. 199 2004 251 263 (Pubitemid 38744521)
114. R.M. Conry, A.F. Lobuglio, M. Wright, L. Sumerel, M.J. Pike, F. Johanning, R. Benjamin, D. Lu, and D.T. Curiel Characterization of a messenger RNA polynucleotide vaccine vector Cancer Res. 55 1995 1397 1400
115. S. Sæbøe-Larssen, E. Fossberg, and G. Gaudernack mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT) J. Immunol. Meth. 259 2002 191 203 (Pubitemid 33124396)
116. H.-M. Zhang, L.-W. Zhang, J. Ren, L. Fan, X.-M. Si, and W.-C. Liu Induction of α-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells Cell. Immunol. 239 2006 144 150 (Pubitemid 44037547)
117. J. Qiu, G.W. Lil, Y.F. Sui, Y.J. Sun, Y.Y. Huang, S.Y. Si, W. Ge, and H.P. Song Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo Hepatogastroenterologica 54 2007 681 687 (Pubitemid 46908461)
118. T. Amano, K. Kajiwara, K. Yoshikawa, J. Morioka, S. Nomura, H. Fujisawa, S. Kato, M. Fujii, M. Fukui, Y. Hinoda, and M. Suzuki Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model J. Neurosurg. 106 2007 638 645 (Pubitemid 46536461)
119. M. Saka, T. Amano, K. Kajiwara, K. Yoshikawa, M. Ideguchi, S. Nomura, H. Fujisawa, S. Kato, M. Fujii, K. Ueno, Y. Hinoda, and M. Suzuki Vaccine therapy with dendritic cells transfected with Il3ra2 mRNA for glioma in mice J. Neurosurg. 708 2009
120. S. Zarei, J.-F. Arrighi, G. Ongara, T. Calzascia, O. Haller, C. Frossard, V. Piguet, P.R. Walker, and C. Hauser Efficient induction of CD8 T-associated immune protection by vaccination with mRNA transfected dendritic cells J. Invest. Dermatol. 121 2003 745 750 (Pubitemid 37239117)
121. H. Yu, L.A. Babiuk, and S. van Drunen Littel-van den Hurk Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA Vaccine 25 2007 1701 1711 (Pubitemid 46176333)
122. K. Dell, C. Klein, and L. Gissmann Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7 Antivir. Ther. 13 2008 495 509 (Pubitemid 352016712)
123. J.-P. Carralot, J. Probst, I. Hoerr, B. Scheel, R. Teufel, G. Jung, H.-G. Rammensee, and S. Pascolo Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines Cell. Mol. Life Sci. 61 2004 2418 2424 (Pubitemid 39382031)
124. H.J. Bontkes, D. Kramer, J.J. Ruizendaal, E.W. Kueter, V.F.I. Van Tendeloo, C.J. Meijer, and E. Hooijberg Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells Gene Ther. 14 2007 366 375 (Pubitemid 46231930)
125. J. Dannull, S. Nair, Z. Su, D. Boczkowski, C. DeBeck, B. Yang, E. Gilboa, and J. Vieweg Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand Blood 105 2005 3206 3213
126. P.R. Hess, D. Boczkowski, S.K. Nair, D. Snyder, and E. Gilboa Vaccination with mRNAs encoding tumor-associated antigens and GM-CSF efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen Cancer Immunol. Immunother. 55 2006 672 683
127. T. Naka, M. Iwahashi, M. Nakamura, T. Ojima, M. Nakamori, K. Ueda, M. Katsuda, M. Miyazawa, K. Ishida, and H. Yamaue Tumor vaccine therapy against recrudescent tumor using dendritic cells simultaneously transfected with tumor RNA and granulocyte macrophage colony-stimulating factor RNA Cancer Sci. 99 2008 407 413 (Pubitemid 351228499)
128. J.G. Hecker, L.L. Hall, and V.R. Irion Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system Mol. Ther. 3 2001 375 384 (Pubitemid 32514654)
129. D.M. Anderson, L.L. Hall, A.R. Ayyalapu, V.R. Irion, M.H. Nantz, and J.G. Hecker Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system Hum. Gene Ther. 14 2003 191 202 (Pubitemid 36423439)
130. J.A. Kyte, G. Kvalheim, S. Aamdal, S. Sæbøe-Larssen, and G. Gaudernack Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination Cancer Gene Ther. 12 2005 579 591 (Pubitemid 40686598)
131. H.J. Bontkes, D. Kramer, J.J. Ruizendaal, C.J.L.M. Meijer, and E. Hooijberg Tumor associated antigen and IL-12 mRNA transfected DCs enhance effector function of natural killer cells and antigen specific T-cells Clin. Immunol. 127 2008 375 384
132. T. Kobayashi, R. Yamanaka, J. Homma, N. Tsuchiya, N. Yajima, S. Yoshida, and R. Tanaka Tumor RNA-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma Cancer Immunol. Immunother. 52 2003 632 637 (Pubitemid 37268196)
133. J.A. Kyte, and G. Gaudernack Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells Cancer Immunol. Immunother. 55 2006 1432 1442 (Pubitemid 44187676)
134. B. Weide, S. Pascolo, B. Scheel, E. Derhovanessian, A. Pflugfelder, T.K. Eigentler, G. Pawelec, I. Hoerr, H.G. Rammensee, and C. Garbe Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients J. Immunother. 32 2009 498 507
135. L.J. Mu, J.A. Kyte, G. Kvalheim, S. Aamdal, S. Dueland, M. Hauser, H. Hammerstad, H. Waehre, N. Raabe, and G. Gaudernack Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients Br. J. Cancer 93 2005 749 756 (Pubitemid 41486433)
136. A.B. Rasmussen, M.B. Zocca, C.M. Bonefeld, M. Von Essen, J.P. Lauritsen, S. Tomra, N. Odum, and C. Geisler Proteasomal targeting and minigene repetition improve cell-surface presentation of a transfected, modified melanoma tumour antigen Scand. J. Immunol. 59 2004 220 227 (Pubitemid 38253556)
137. A. Bonehill, S. Tuyaerts, A.M. Van Nuffel, C. Heirman, T.J. Bos, K. Fostier, B. Neyns, and K. Thielemans Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA Mol. Ther. 16 2008 1170 1180 (Pubitemid 351737084)
138. D. Weissman, H. Ni, D. Scales, A. Dude, J. Capodici, K. McGibney, A. Abdool, S.N. Isaacs, G. Cannon, and K. Karikó HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response J. Immunol. 165 2000 4710 4717
139. H. Ni, J. Capodici, G. Cannon, D. Communi, J.M. Boeynaems, K. Karikó, and D. Weissman Extracellular mRNA induces dendritic cell activation by stimulating tumor necrosis factor-alpha secretion and signaling through a nucleotide receptor J. Biol. Chem. 277 2002 12,689 12,696
140. I. Hoerr, R. Obst, H.G. Rammensee, and G. Jung In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies Eur. J. Immunol. 30 2000 1 7 (Pubitemid 30011760)
141. F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, F. Lipford, H. Wagner, and S. Bauer Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 Science 303 2004 1526 1529 (Pubitemid 38314424)
142. K. Kariko, H. Ni, J. Capodici, J. Lamphier, and D. Weissman mRNA is an endogenous ligand for Toll-like receptor 3 J. Biol. Chem. 279 2004 12,542 12,550
143. B. Scheel, R. Teufer, J. Probst, J.-P. Carralot, J. Geginat, M. Radsak, D. Jarrossay, H. Wagner, G. Jung, H.G. Rammensee, I. Hoerr, and S. Pascolo Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA Eur. J. Immunol. 35 2005 1557 1566 (Pubitemid 40691436)
144. E.L. Smits, P. Ponsaerts, Z.N. Berneman, and V.F.I. Van Tendeloo The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy Oncologist 13 2008 859 875
145. F. Martinon, S. Krishnan, G. Lenzen, R. Magné, E. Gomard, J.G. Guillet, J.P. Lévy, and P. Meulien Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA Eur. J. Immunol. 23 1993 1719 1722 (Pubitemid 23218089)
146. E. Roesler, R. Weiss, E.E. Weinberger, A. Fruehwirth, A. Stoecklinger, S. Mostböck, F. Ferreira, J. Thalhamer, and S. Scheiblhofer Immunize and disappear - safety optimized mRNA vaccination with a panel of 29 allergens J. Allergy Clin. Immunol. 124 2009 1070 1077
147. W. Zhang, H. Long, Z. Yuan, Z. Xie, J. Wang, H. Hamada, and X. Cao Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin Hum. Gene Ther. 10 1999 1151 1161 (Pubitemid 29233384)